• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Chorionic Gonadotropin Labeling Change

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011

Summary View

 

Novarel

Pregnyl

Chorionic Gonadotropin for Injection

 

WARNINGS

  • Anaphylaxis and other hypersensitivity reactions have been reported with urinaryderived

    hCG products.